Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gill

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 21, 2023
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplantLindsey Chippendale, Craig W Freyer, Alison Carulli, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
An integrated enzymatic and computational pipeline for quantifying off-target base-editingAlexander G McFarland, Soon-Keat Ooi, Davin Tafuri, et al.
Transplantation and Cellular Therapy|August 2, 2021
Characterization of Pericarditis following Allogeneic Hematopoietic Cell TransplantationCraig W Freyer, Michael Fradley, David Madnick, et al.
Kidney International|November 2, 2025
Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T cellsBurcin Altun, Gexin Zhao, Baomei Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2014
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioningRan Reshef, Elizabeth O Hexner, Alison W Loren, et al.
Blood|April 16, 2026
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistenceJoseph S Durgin, Shin H Seo, Shadab Kazmi, et al.
Nature Biomedical Engineering|February 22, 2022
Rapid manufacturing of non-activated potent CAR T cellsSaba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz, et al.
Bone Marrow Transplantation|May 26, 2018
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, Noelle V Frey, Elizabeth O Hexner, et al.
Blood|April 1, 2014
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cellsJenny Zhang, Dereje Jima, Andrea B Moffitt, et al.
Blood Advances|June 27, 2020
Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failureBrian J Ball, Christopher A Famulare, Eytan M Stein, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 21, 2023
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplantLindsey Chippendale, Craig W Freyer, Alison Carulli, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
An integrated enzymatic and computational pipeline for quantifying off-target base-editingAlexander G McFarland, Soon-Keat Ooi, Davin Tafuri, et al.
Transplantation and Cellular Therapy|August 2, 2021
Characterization of Pericarditis following Allogeneic Hematopoietic Cell TransplantationCraig W Freyer, Michael Fradley, David Madnick, et al.
Kidney International|November 2, 2025
Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T cellsBurcin Altun, Gexin Zhao, Baomei Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2014
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioningRan Reshef, Elizabeth O Hexner, Alison W Loren, et al.
Blood|April 16, 2026
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistenceJoseph S Durgin, Shin H Seo, Shadab Kazmi, et al.
Nature Biomedical Engineering|February 22, 2022
Rapid manufacturing of non-activated potent CAR T cellsSaba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz, et al.
Bone Marrow Transplantation|May 26, 2018
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, Noelle V Frey, Elizabeth O Hexner, et al.
Blood|April 1, 2014
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cellsJenny Zhang, Dereje Jima, Andrea B Moffitt, et al.
Blood Advances|June 27, 2020
Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failureBrian J Ball, Christopher A Famulare, Eytan M Stein, et al.
Pageof 15